NCT00863915View on ClinicalTrials.gov

A Relative Bioavailability Study of Ramipril 10 mg Capsules Administered Orally as a Sprinkle on Applesauce

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

October 31, 2004

Primary Completion Date

October 31, 2004

Study Completion Date

October 31, 2004

Conditions
Healthy
Interventions
DRUG

Ramipril10 mg Capsules, single dose

A: Experimental Subjects received Purepac formulated products sprinkled on one tablespoonful of applesauce

DRUG

Atlace® 10 mg capsules, single dose

B: Active comparator Subjects received Monarch Pharmaceuticals Inc. formulated products sprinkled on one tablespoonful of applesauce

Trial Locations (1)

78759

CEDRA Clinical Research, LLC, Austin

Sponsors

Lead Sponsor

Actavis Inc.
All Listed Sponsors
lead

Actavis Inc.

INDUSTRY

NCT00863915 - A Relative Bioavailability Study of Ramipril 10 mg Capsules Administered Orally as a Sprinkle on Applesauce | Biotech Hunter | Biotech Hunter